Hagen von Briesen

Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks

Heiko Zimmermann, Anke Schultz, Anja Germann, 2018, PloS one.

Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.

Hagen von Briesen, H. von Briesen, J. Kreuter, 2005, Biomaterials.

Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles.

Sylvia Wagner, Hagen von Briesen, H. von Briesen, 2008, Bioconjugate chemistry.

A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis

Christina Backes, Eckart Meese, Andreas Keller, 2015, European Respiratory Journal.

Biocompatible micro-sized cell culture chamber for the detection of nanoparticle-induced IL8 promoter activity on a small cell population

Albert Duschl, Adam Sossalla, Hagen Thielecke, 2011, Nanoscale research letters.

Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.

Hagen von Briesen, Andreas Zimmer, Dirk Lochmann, 2004, Journal of controlled release : official journal of the Controlled Release Society.

An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials

Heiko Zimmermann, Andreas Meyerhans, Anke Schultz, 2012, PloS one.